July 31, 2012
Gene sequencing company Illumina Inc. and one of its shareholders agreed Monday to resolve the investor's suit, which he had intended to use as an antidote to Illumina's poison pill efforts to block Roche Holding AG's hostile takeover attempt.
March 07, 2012
Gene-sequencing firm Illumina Inc. was hit Tuesday with a proposed shareholder class action intended as an antidote to the company's recent poison pill efforts to resist a hostile takeover by Roche Holding AG.